8th Asian Biologics and Biosimilars Congress
August 10-12, 2017 Beijing, China

Upcoming Conference

Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs CONTACT
Asian Biosimilars 2017
Home
Gallery
Asian Biosimilars 2017 Report
Conference Series hosted the 8th Asian Biologics and Biosimilars Congress at Hotel Radisson Blu Beijing, China during August 10-12, 2017. The conference was designed around the theme of “Biosimilars- Uncovering an Innovation in Motion” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.
 
Asian Biosimilars 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilar.
 
Conference Series would like to convey a warm gratitude to all the Honourable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Asian Biosimilars 2017.
 
Kamali Chance, QuintilesIMS, USA
 
Asif Mahmood, Pfizer, USA
 
Raymond Huml, QuintilesIMS, USA
 
Jianguo Yang, Abpro, USA
 
Oxana Iliach, QuintilesIMS, Canada
 
Divya Chadha Manek, NIHR, UK
 
Charu Manaktala, QuintilesIMS, India
 
We on behalf of the conference we thank our collaborators and media partners for their wonderful marketing of the event. Conference Series also took the privilege of felicitating Asian Biosimilars 2017 Organizing Committee Members, Keynote Speakers, Chairpersons and Co-chairpersons whose support made conference a great success.
 
With the enormous feedback from the participants and supporters of Asian Biosimilars 2017, we are glad to announce the 9th Asian Biologics and Biosimilars Congress during August 20-22, 2018 at Tokyo, Japan.


Expert Presentations
Kamali Chance

Vice President

USA
Robert Salcedo

President and Founder

USA
Hossein Pakdaman

President

Iran
Oxana Iliach

Sr. Director

Canada
Raymond Huml

Vice President

USA
Charu Manaktala

Senior Medical Director

India
Beat Fluhmann

Director

Switzerland
Asif Mahmood

Disease Area Cluster Lead

USA
Jianguo Yang

President / CEO

USA
Zhaoyang (Megan) Li

Director

USA
Luis Ulloa

Professor of Surgery

USA
Divya Chadha Manek

Head of Commercial Business Development

UK
Richard Littlewood

CEO Founder

UK
Darius Panaligan

Vice President, Global Head

Switzerland
Frank Cheng

CEO & Senior GMP Consultant

China
Conference: Asian Biosimilars 2017, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact: biosimilarsasia@pharmaceuticalconferences.org
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved